Poseida Therapeutics Inc (PSTX)
9.49
+0.01
(+0.11%)
USD |
NASDAQ |
Dec 24, 16:00
Poseida Therapeutics Shareholders Equity (Quarterly): 87.21M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Galectin Therapeutics Inc | -92.48M |
| Revance Therapeutics Inc | -163.03M |
| Sage Therapeutics Inc | 551.84M |
| Alector Inc | 118.93M |
| Phathom Pharmaceuticals Inc | -187.11M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 293.58M |
| Total Liabilities (Quarterly) | 206.37M |
| Debt to Equity Ratio | 0.6755 |
| Current Ratio | 3.203 |
| Net Debt Paydown Yield | -0.04% |